Ashley Tan quit JP Morgan for a career gap because she felt like she was wasting her life. Her time away changed her career ...

Former Macquarie executive Dean Hoang’s new job calls for investing J.P. Morgan interval fund for individual investors.

Analyst Eric Joseph of J.P. Morgan maintained a Buy rating on Rocket Pharmaceuticals (RCKT – Research Report), retaining the price target of ...

A beloved figure in the theatrical community, she redefined the role of dramaturg, influencing playwrights like David Adjmi and David Henry Hwang.

On Friday, bluebird bio Inc (BLUE) stock saw a decline, ending the day at $0.32 which represents a decrease of $-0.04 or -11.11% from the prior close of $0.36. The stock opened at $0.37 and touched a ...

Brian Brooks, former Binance.US CEO, is shortlisted for several US regulator roles. Kalshi odds name him second place for SEC Chair.

Scotland's finest corporate financiers, accountants, bankers, funders, lawyers and M&A professionals have been celebrated at the Scotland Dealmakers Awards. Insider UK joined ...

J.P. Morgan Private Bank today released its 2025 Global Investment Outlook, Building on Strength, which defines the pivotal themes poised to shape market dynamics in the upcoming year. "It was a year ...

JPMorgan Chase & Co. cut shares of bluebird bio (NASDAQ:BLUE – Free Report) from a neutral rating to an underweight rating in ...

On Thursday, bluebird bio Inc (BLUE) stock saw a decline, ending the day at $0.36 which represents a decrease of $-0.02 or -5.26% from the prior close of $0.38. The stock opened at $0.37 and touched a ...

On Thursday, Bluebird Bio Inc. (NASDAQ:BLUE) reported a third-quarter EPS loss of 31 cents, compared to a loss of 80 cents a ...

(BLUE) stock downgraded by Bank of America and J.P. Morgan after the company's Q3 2024 results. Read more here.